1.Clinical Observation of Telbivudine Combined with Adefovir Dipivoxil in Long-term Treatment of Active Hep-atitis B Cirrhosis
Yegang LI ; Xibang GUO ; Xia ZHU
China Pharmacy 2015;26(35):4984-4986
OBJECTIVE:To observe therapeutic efficacy and safety of telbivudine combined with adefovir dipivoxil in long-term treatment of active hepatitis B cirrhosis. METHODS:76 patients with active hepatitis B cirrhosis in our hospital were ran-domly divided into observation group and control group,with 38 cases in each group. Control group was treated with adefovir dip-ivoxil 10 mg,qd;observation group was additionally treated with telbivudine 600 mg,qd,on the basis of control group. Both groups received 2-year consecutive treatment. TBIL,ALB,ALT,AST,rate of HBV-DNA negative conversion and serum virologi-cal index were compared between 2 groups after treatment,and clinical efficacy and ADR were also compared between 2 groups. RESULTS:After treatment,the levels of AST,ALB,ALT and TBIL in observation group were significantly better than the control group,with statistical significance(P<0.05);the rate of HBV-DNA negative conversion,the decreased of serum virus in observa-tion group were significantly higher than control group after 1 and 2 years treatment,with statistical significance(P<0.05). The to-tal effective rate of observation group was significantly higher than that of control group,with statistically significance(P<0.05). No obvious ADR was found in 2 groups. CONCLUSIONS:Telbivudine combined with adefovir dipivoxil can significantly improve the liver function of patients with hepatitis B cirrhosis and have good long-term therapeutic efficacy with high safety.
2. Characteristics analysis of AIDS complicated with severe pneumonia
Weiwei CHEN ; Guoliang YU ; Yegang LI
Chinese Journal of Experimental and Clinical Virology 2018;32(3):277-281
Objective:
To investigate the characteristics and pathogenic characteristics of acquired immunodeficiency syndrome (AIDS) complicated with severe pneumonia.
Methods:
The clinical data of patients with AIDS complicated with severe pneumonia who were hospitalized and treated in the First People′s Hospital of Linhai City from January 2016 to January 2018 were collected. The laboratory test results, imaging findings, distribution of pathogens, mixed infections of pathogens, treatment and outcomes were statistically analyzed. The influencing factors of the prognosis were tested by
3. Risk nomogram model for predicting the postoperative upgrade to pT3a of cT1 renal cancer
Qiliang CAI ; Jintao LI ; Chuanfeng LIU ; Dingrong ZHANG ; Shenzhe MA ; Zunke XIE ; Yegang CHEN ; Wei ZHANG ; Yuanjie NIU
Chinese Journal of Urology 2019;40(10):742-746
Objective:
To evaluate the risk factors of postoperative upgrade to pT3a of cT1 renal cell carcinoma, and to establish a nomogram prediction model to improve the ability of predicting locally advanced renal cell carcinoma and provide a reference for clinical surgical decision-making.
Methods:
Clinical data of 1 376 patients with cT1 (diameter ≤ 7 cm) renal tumor hospitalized for surgery from January 2010 to December 2016 were retrospectively analyzed. There were 979 males and 397 females, with the mean age of (57.65±10.92) years. The mean body mass index (BMI) was (25.47±3.27) kg/m2 and the average tumor size was (4.02±1.52) cm. There were 711 tumors on the left and 665 on the right. There were 363 cases with clinical symptoms, 567 patients with smoking history , 732 cases with history of chronic disease. There were 289 cases with tumor necrosis, 636 cases with tumor protrusion, 822 cases with irregular tumor , and 738 cases with renal sinus compression. Partial nephrectomy and radical nephrectomy were performed in 396 cases and 980 cases respectively. Mann-whitney
4. A case report of plasmacytoid urothelial carcinoma of the ureter
Tianjie LAN ; Zunke XIE ; Chuanfeng LIU ; Shenze MA ; Qiliang CAI ; Yegang CHEN ; Gang LI ; Guang SUN ; Yuanjie NIU
Chinese Journal of Urology 2020;41(1):65-66
Primary ureteral plasmacytoid carcinomas is a rare tumor with high grade and poor diagnosis. Pathological and immunohistochemical staining play an extremely key role in diagnosis since there is no specific clinical and radiological evidence. The surgical removement is the first line treatment. Herein, we report a case of ureteral plasmacytoid carcinoma that was well controlled with multimodal therapy.